NCT04508972View on ClinicalTrials.gov

The VOICE-COVID-19

CompletedOBSERVATIONAL
Enrollment

267

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Covid19
Interventions
DEVICE

Alexa Amazon

To test the use of the Amazon Alexa device as a tool to conduct screening of employees and patients at the point of entry into the Heart Failure (HF) Clinic of the McGill University Health Center.

Trial Locations (1)

H4A 3J1

Muhc-Rimuhc, Montreal

All Listed Sponsors
collaborator

Amazon Web Services (AWS) Canada

UNKNOWN

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT04508972 - The VOICE-COVID-19 | Biotech Hunter | Biotech Hunter